Suchergebnisse - "Fang, Zige"

PubPharm (11)

1

Effects of preoperative needle biopsy for lung cancer on survival and recurrence : a systematic review and meta-analysis

enthalten in: Surgery today | 2024

von Hao, M. | Fang, Z. | Ding, J. | +3

2

PARP inhibitor plus chemotherapy versus chemotherapy alone in patients with triple-negative breast cancer : a systematic review and meta-analysis based on randomized controlled trials

enthalten in: Cancer chemotherapy and pharmacology | 2023

von Li, C. | Hao, M. | Fang, Z. | +5

3

PARP inhibitor plus chemotherapy versus chemotherapy alone in patients with triple-negative breast cancer: a systematic review and meta-analysis based on randomized controlled trials

enthalten in: Cancer chemotherapy and pharmacology | 2023

von Li, C. | Hao, M. | Fang, Z. | +5

4

Efficacy and safety of empagliflozin at different doses in patients with type 2 diabetes mellitus : A network meta-analysis based on randomized controlled trials

enthalten in: Journal of clinical pharmacy and therapeutics | 2022

von Wu, Q. | Liu, M. | Fang, Z. | +4

5

The efficacy and toxicity of maintenance therapy with bevacizumab plus pemetrexed versus bevacizumab/pemetrexed alone for stage IIIB/IV nonsquamous non-small cell lung cancer : A meta-analysis of randomized controlled trials

enthalten in: Journal of clinical pharmacy and therapeutics | 2022

von Liu, M. | Luo, N. | Fang, Z. | +5

6

Efficacy and safety of netarsudil/latanoprost fixed-dose combination vs. monotherapy in open-angle glaucoma or ocular hypertension : A systematic review and meta-analysis of randomized controlled trials

enthalten in: Frontiers in medicine | 2022

von Luo, N. | Jiang, X. | Hao, M. | +3

7

The efficacy and toxicity of maintenance therapy with bevacizumab plus pemetrexed versus bevacizumab/pemetrexed alone for stage IIIB/IV nonsquamous non‐small cell lung cancer : A meta‐analysis of randomized controlled trials

enthalten in: Journal of clinical pharmacy and therapeutics | 2022

von Liu, M. | Luo, N. | Fang, Z. | +5

8

Efficacy and safety of empagliflozin at different doses in patients with type 2 diabetes mellitus : A network meta‐analysis based on randomized controlled trials

enthalten in: Journal of clinical pharmacy and therapeutics | 2022

von Wu, Q. | Liu, M. | Fang, Z. | +4

9

The benefits and risks of CTLA4 inhibitor plus PD1/PDL1 inhibitor in stage IIIB/IV non-small cell lung cancer : A systematic analysis and meta-analysis based on randomized controlled trials

enthalten in: Journal of clinical pharmacy and therapeutics | 2021

von Liu, Q. | Fang, Z. | Liu, M. | +5

10

Topotecan plus Platinum-Based Chemotherapy versus Etoposide plus Platinum-Based Chemotherapy for Small-Cell Lung Cancer : A Systematic Review and Meta-Analysis of Randomized Controlled Trials

enthalten in: Chemotherapy | 2021

von He, M. | Wu, B. | Liu, Q. | +6